INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Keryx Biopharmaceuticals Inc. & Encourages I...
August 08 2016 - 11:33AM
Business Wire
Lundin Law PC (the “Firm”) announces that a class action lawsuit
has been filed against Keryx Biopharmaceuticals Inc. ("Keryx" or
the "Company") (Nasdaq: KERX) concerning possible violations of
federal securities laws between February 25, 2016 and August 1,
2016 (the “Class Period”). Investors, who purchased or otherwise
acquired shares during the Class Period, should contact the Firm in
advance of the October 3, 2016 lead plaintiff motion
deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esquire, of Lundin Law PC, at
888-713-1033, or e-mail him at brian@lundinlawpc.com.
No class has been certified in the above action. Until a class
is certified, you are not considered represented by an attorney.
You may also choose to do nothing and be an absent class
member.
According to the complaint, the Company made false and
misleading statements and/or failed to disclose that Keryx was
experiencing production-related difficulties in converting API to
finished drug product; that the issue was resulting in decreased
production yields of finished drug product; that the Company
exhausted its reserve of finished drug product; and as a result of
the above, Keryx’s statements about its business, operations and
prospects were false and misleading and/or lacked a reasonable
basis at all relevant times.
Lundin Law PC was founded by Brian Lundin, a securities
litigator based in Los Angeles dedicated to upholding shareholders’
rights.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160808005836/en/
Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile:
888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Apr 2023 to Apr 2024